Wickström, Ronny
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 18 July 2023
Accepted: 8 September 2023
First Online: 17 October 2023
Declarations
:
: R. Wickström has served on scientific advisory boards for GW Pharma and Octapharma; has received speaker honoraria from Eisai, UCB and Sanofi. R. Wickström declares that he has no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.